Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Traws Pharma, Inc.ONTX · Entity 8032 | SVP - Product Development | July 09, 2020 | July 10, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Traws Pharma, Inc.
Report date July 09, 2020 · Filed July 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $0.56 · Expires 2030-07-09 | Direct | 418,600 |
Reported balance
After 2020-07-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-07-09 · Grant · Acquired 418,600 · Balance 418,600 F1: These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. |
Filing footnotes · ownership attribution and instrument terms
F1: These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 09, 2020 Filed Jul 10, 2020 21:43 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Appreciation Right · Derivative | 418,600 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001179110-20-008210 · edgar.xml · derivative · entry 1 Maniar Manoj · CIK 0001642906 · SVP - Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,600 Underlying: Common Stock · 418,600 shares Expires 2030-07-09 F1 · derivative.exercise_date: These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 14:05 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 43,000 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001179110-19-013137 · edgar.xml · derivative · entry 1 Maniar Manoj · CIK 0001642906 · SVP - Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,000 Underlying: Common Stock · 43,000 shares Expires 2029-12-20 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| December 12, 2018 Filed Apr 8, 2019 23:19 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 5,000 | $0.00 Strike: $3.41 | $0.00 |
DisclosureSEC source: 0001179110-19-004834 · edgar.xml · derivative · entry 1 Maniar Manoj · CIK 0001642906 · SVP - Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2028-12-12 F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 21:23 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 300,000 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001179110-18-010007 · edgar.xml · derivative · entry 1 Maniar Manoj · CIK 0001642906 · SVP - Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2028-07-26 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:51 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 28,609 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001179110-18-000603 · edgar.xml · derivative · entry 1 Maniar Manoj · CIK 0001642906 · SVP - Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,609 Underlying: Common Stock · 28,609 shares Expires 2028-01-03 F1 · derivative.exercise_date: These options vest over three years in 36 equal monthly installments. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 18:37 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 19,413 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001179110-17-001045 · edgar.xml · derivative · entry 1 Maniar Manoj · CIK 0001642906 · SVP - Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,413 Underlying: Common Stock · 19,413 shares Expires 2027-01-17 F1 · derivative.exercise_date: These options vest over three years in 36 equal monthly installments. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:31 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option · Derivative | 5,587 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001179110-16-033196 · edgar.xml · derivative · entry 1 Maniar Manoj · CIK 0001642906 · SVP - Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,587 Underlying: Common Stock · 5,587 shares Expires 2026-12-15 F1 · derivative.exercise_date: These options vest over three years in 36 equal monthly installments. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.